HHS joined with ApiJect Systems America (ApiJect), a public-benefit corporation, to create a U.S.-based high-volume, “surge” drug packaging solution using Blow-Fill-Seal (BFS), which is a process used in sterile manufacturing facilities worldwide that features a small medical-grade plastic container that holds a prefilled volume of medicines or vaccines.

Use this handy form to search our extensive database of stock symbols. Its substantial financial support signals to others in the investment community the vital and central role that RAPID, as a public-private partnership led by the HHS Assistant Secretary for Preparedness and Response, will play in the war against the current pandemic, as well as future health emergencies and threats.” See ApiJect at Jefferies to Lead Urgent Initiative to Raise up to $1 Billion in Private Capital to Support Newly Announced Public-Private Partnership Developing a High-Volume Emergency Drug Packaging Solution on U.S. ApiJect Systems America is dedicated to making injectable medicines safe and available for everyone. By building a network using high-speed, high volume Blow-Fill-Seal plastics technology, … ApiJect is currently contracted with the U.S. Government to create and manage the RAPID Consortium, which when fully funded and built out, will provide the capability to fill and finish up to 330 million pre-filled syringes per month to respond to national or smaller scale health emergencies. Messrs. Handler and Friedman also noted, “Our support of RAPID puts us right where all leadership companies belong -- on the front lines of the war against this global threat. Looking for a stock symbol, but only know the company name, or a portion of the company name? As the first private-sector entity to join this vital public health initiative, Jefferies will support the initiative by providing access to the firm’s vast client network, experienced management team, global financial resources and an immediate initial seed capital commitment of at least $10 million to jumpstart the RAPID network as quickly as possible. RAPID will combine this well-established technology with an innovative interlocking needle hub to achieve population-scale volumes of prefilled syringes. Jefferies Financial Group Inc. is a diversified financial services company engaged in investment banking and capital markets, asset management and direct investing. We believe that ApiJect and RAPID’s goal of creating hundreds of millions of prefilled syringes will make that possible.” ApiJect Systems America, Inc., is a public benefit corporation dedicated to making injectable medicines safe and available for everyone. Jefferies Financial Group, Inc. (NYSE: JEF) today announced it is the first private-sector company to support a newly established public-private consortium launched by the U.S. Department of Health and Human Services (HHS) through its Office of the Assistant Secretary for Preparedness and Response (ASPR). Simply type the company name, … About ApiJect ApiJect Systems America is dedicated to making injectable medicines safe and available for everyone. This new consortium called RAPID – Rapid Aseptic Packaging of Injectable Drugs – is intended to establish critically needed surge capacity “to fill and finish, on a rapid basis, hundreds of millions of prefilled syringes to respond quickly and efficiently to widespread health emergencies, such as the novel coronavirus outbreak.” (HHS Public Announcement, March 18, 2020 Rich Handler, CEO of Jefferies, and Brian Friedman, President of Jefferies, commented: “All of us at Jefferies are deeply concerned about, and personally impacted by, the COVID-19 pandemic.